Chemicals and pharmaceuticals · CDTX

Cidara Therapeutics, Inc.

29 filings mentioning 11 of the compliance and risk topics we track, most recently 2025-11-14. Every row links to the filing on EDGAR.

Page built . This page is derived from the framework corpus, which changes when the corpus is extended rather than daily.

29filings we hold
11topics disclosed
Chemicals and pharmaceuticalsindustry
CAbased in

Across 29 filings we hold, Cidara Therapeutics, Inc. has written down 11 of the topics we track. That places it 30 of 228 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

Cidara Therapeutics, Inc. has written 11 of our tracked topics into its filings. What it disclosed is public. What that now obligates is not, and it is 531 controls.From SEC filings and our framework corpus

What it discloses

Tracked topics appearing in this company's filings, most frequent first. Each opens the topic, where you can see who else files it and what it obligates.

Ransomware19
Cross Border Data Transfer18
Material Weakness7
Internal Control7
Data Residency6
Restatement5
Internal Control Over Financial Reporting Material Weakness3
Regulatory Reporting2
Enforcement Action1
Records Retention1
Regulatory Investigation1
TopicFilingsMost recent
Ransomware192025-11-14
Cross Border Data Transfer182025-11-06
Material Weakness72025-11-14
Internal Control72025-11-14
Data Residency62022-11-03
Restatement52024-11-26
Internal Control Over Financial Reporting Material Weakness32022-11-03
Regulatory Reporting22021-05-13
Enforcement Action12025-11-14
Records Retention12025-11-06
Regulatory Investigation12025-06-25

What this obligates

Every instrument below governs something Cidara Therapeutics, Inc. has written into a filing. This maps to obligations within those frameworks. It is not a finding that the company has failed any of them, and nothing here establishes noncompliance.

ISO 27001:2013114
ISO 27001:2022112
NIST Cybersecurity Framework 2.0106
GDPR40
ISO 37001:201639
ASD Strategies to Mitigate Cyber Security Incidents37
ISO 3700126
COSO Internal Control23
US Foreign Corrupt Practices Act (FCPA)18
Romania Law No. 190/2018 on Data Protection Measures (GDPR Implementation)16

10 frameworks, 531 controls between them, deduplicated across topics.

And what those same controls reach into

The controls behind those frameworks also appear in the instruments below, which suggests increased attention to them follows from the same work rather than from a separate programme.

ISO 27701:2019781
ISO 27002:2022496
ISO 22301:2019359
ISO/IEC 42001:2023343
NIS2 Directive224
PCI DSS 4.0165
COBIT 2019148

Tell me when Cidara Therapeutics, Inc. files something new

One email when there is a new SEC filing, naming what it is and what our corpus says it puts in scope. Nothing else, and one click to stop.

When it filed

Filings we hold, by year. Hover a bar for the count. Peak 9 in 2024.

19
20
21
22
23
24
25

Recent filings

FiledFormItem
2025-11-148-KEntry into a material agreement, Regulation FD disclosure, Financial statements and exhibitsfiling
2025-11-0610-Qfiling
2025-08-0710-Qfiling
2025-06-258-KOther material event, Financial statements and exhibitsfiling
2025-05-0810-Qfiling
2025-03-0610-Kfiling
2024-11-268-KEntry into a material agreement, Item 3.02, Other material eventfiling
2024-11-0710-Qfiling
2024-08-1310-Qfiling
2024-05-1510-Qfiling
2024-04-298-K/AEntry into a material agreement, Item 1.02, Completion of an acquisitionfiling
2024-04-248-KEntry into a material agreement, Item 1.02, Item 3.02filing

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry classification. Each opens side by side with this one.

CompanyFilings
FDMT4D Molecular Therapeutics, Inc.16compare →
ABPAbpro Holdings, Inc.9compare →
APACCELERON PHARMA INC3compare →
ATACORDA THERAPEUTICS INC13compare →
ABOSAcumen Pharmaceuticals, Inc.5compare →
ADAPAdaptimmune Therapeutics PLC9compare →

Where this goes next

  1. The topic Cidara Therapeutics, Inc. files on most, and every other company that files on it:Ransomware →
  2. How the rest of chemicals and pharmaceuticals compares, and who files most:Chemicals and pharmaceuticals →
  3. The failures that these disclosures usually turn out to be:How compliance programmes fail →
  4. What moved across every company we hold this week:What changed →
  5. And how much of any framework you are already carrying without knowing:What you already have →
New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down, in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition